Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial
DiscussionThe results of this trial will be of clinical relevance because there are no established guidelines on the treatment and management of HIV-associated CLD in children in sub-Saharan Africa, where 80% of the world ’s HIV-infected children live and where HIV-associated CLD is highly prevalent.Trial registrationClinicalTrials.gov,NCT02426112. Registered on 21 April 2015.
Source: Trials - Category: Research Source Type: clinical trials
More News: African Health | Antimicrobial Resistance | Azithromycin | Child Development | Children | Gastroenteritis | Gastroenterology | Laboratory Medicine | Malaria | Malawi Health | Research | Respiratory Medicine | Study | Zimbabwe Health | Zithromax